Study guide

2.1 Hemodynamic Monitoring and Interpretation

Board Certified Critical Care Pharmacist Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pathophysiology and Recognition of Critical Illness

1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness

2 Chapter 2: Medical Devices and Circulatory Support

2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care

3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management

3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation

4 Chapter 4: Vasoactive and Inotropic Therapy in Shock

4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock

5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)

5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness

6 Chapter 6: Cardiovascular Emergencies

6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias

7 Chapter 7: Pulmonary and Infectious Diseases in the ICU

7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU

8 Chapter 8: Neurocritical Care

8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury

9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies

9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy

10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition

10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral

11 Chapter 11: Quality, Safety, and Clinical Guidelines

11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions

12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine

12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

13 Chapter 13: Treatment Planning and Care Coordination

13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education

2.1 Hemodynamic Monitoring and Interpretation

Key Takeaways Explain This Topic AI

Pulmonary artery catheters (PACs) provide direct measurement of right-sided heart pressures and mixed venous oxygen saturation (SvO2).

Normal Central Venous Pressure (CVP) ranges from 2-6 mmHg, indicating right ventricular preload.

Systemic Vascular Resistance (SVR) is a key indicator of left ventricular afterload; normal is 800-1200 dynes/sec/cm^-5.

Arterial lines provide continuous blood pressure monitoring and frequent arterial blood gas sampling but do not provide cardiac output data alone.

Last updated: July 2026

Hemodynamic monitoring is fundamental in the ICU to assess cardiovascular function, fluid status, and tissue perfusion. It provides real-time data to guide fluid resuscitation, vasopressor use, and inotropic support.

Arterial Lines

Arterial lines are the most common invasive hemodynamic monitoring device. Placed typically in the radial, femoral, or brachial artery, they provide continuous, beat-to-beat blood pressure monitoring. This is essential for patients requiring vasoactive infusions or those with severe hypotension or hypertension. Furthermore, arterial lines allow for frequent arterial blood gas (ABG) sampling without repeated needle sticks.

The Arterial Waveform

Understanding the arterial waveform is critical. The normal waveform has several components:

Systolic Upstroke: Represents left ventricular ejection. A steep upstroke indicates strong contractility.

Systolic Peak: The maximum pressure during systole (systolic blood pressure).

Dicrotic Notch: Represents the closure of the aortic valve, marking the end of systole and the beginning of diastole.

Diastolic Run-off: The continuous decline in pressure as blood flows into the peripheral circulation.

End-Diastolic Pressure: The lowest point before the next upstroke (diastolic blood pressure).

Overdamping (sluggish waveform, loss of dicrotic notch) can underestimate systolic pressure, while underdamping (artifactual spikes) can overestimate it. The mean arterial pressure (MAP), which is the most accurate reflection of tissue perfusion, remains relatively consistent regardless of damping.

Central Venous Catheters (CVCs)

CVCs are used to measure Central Venous Pressure (CVP), which reflects the pressure in the right atrium or the superior vena cava.

Normal Range: 2-6 mmHg (or 3-8 cm H2O)

Interpretation: CVP is traditionally used as an indicator of right ventricular preload and intravascular volume status. However, its utility as a sole predictor of fluid responsiveness is limited. A low CVP (< 2 mmHg) may indicate hypovolemia, while a high CVP (> 8-10 mmHg) can indicate right ventricular failure, volume overload, pulmonary hypertension, or cardiac tamponade.

Pulmonary Artery Catheters (PACs)

Also known as Swan-Ganz catheters, PACs provide comprehensive hemodynamic data. Inserted through a central vein, they pass through the right atrium, right ventricle, and into the pulmonary artery.

Key Measurements and Normal Values

  • Parameter Normal Range Clinical Significance
  • Right Atrial Pressure (RAP / CVP) 2-6 mmHg Right ventricular preload
  • Pulmonary Artery Pressure (PAP) Quarter over dime (approx 25/10 mmHg) Right ventricular afterload
  • Pulmonary Artery Wedge Pressure (PAWP / PCWP) 8-12 mmHg Left ventricular preload / Left atrial pressure
  • Cardiac Output (CO) 4-8 L/min Total blood flow per minute
  • Cardiac Index (CI) 2.5-4.0 L/min/m^2 CO adjusted for body surface area
  • Systemic Vascular Resistance (SVR) 800-1200 dynes/sec/cm^-5 Left ventricular afterload
  • Pulmonary Vascular Resistance (PVR) 100-250 dynes/sec/cm^-5 Right ventricular afterload
  • Interpreting Shock States with PAC Data

PACs are incredibly useful for differentiating types of shock:

Hypovolemic Shock: Low CVP, Low PAWP, Low CO/CI, High SVR (compensatory vasoconstriction).

Cardiogenic Shock: High CVP, High PAWP, Low CO/CI, High SVR.

Distributive Shock (e.g., Sepsis): Low to normal CVP, Low to normal PAWP, High CO/CI (initially), Low SVR (massive vasodilation).

Obstructive Shock (e.g., Massive PE): High CVP, Low PAWP, Low CO/CI, High SVR.

Mixed and Central Venous Oxygen Saturation (SvO2 and ScvO2)

These values reflect the balance between oxygen delivery (DO2) and oxygen consumption (VO2).

SvO2 (Mixed Venous O2 Saturation): Measured from the distal port of a PAC (pulmonary artery). It represents true mixed venous blood from the superior vena cava, inferior vena cava, and coronary sinus. Normal is 65-75%.

ScvO2 (Central Venous O2 Saturation): Measured from a CVC in the superior vena cava. It typically runs about 5% higher than SvO2 (normal > 70%).

A low SvO2/ScvO2 indicates inadequate oxygen delivery (low CO, anemia, hypoxia) or increased oxygen consumption (fever, shivering, pain, seizures). A high SvO2/ScvO2 indicates decreased oxygen extraction (e.g., mitochondrial dysfunction in sepsis, cyanide toxicity, hypothermia).

Dynamic Parameters of Fluid Responsiveness

Given the limitations of static measures like CVP, dynamic parameters are increasingly preferred. These include:

Stroke Volume Variation (SVV) and Pulse Pressure Variation (PPV): Measured via advanced arterial line analytics. Values > 12-13% in mechanically ventilated patients (without spontaneous breaths and in normal sinus rhythm) suggest fluid responsiveness.

Passive Leg Raise (PLR): Transfers venous blood from the legs to the central circulation (an auto-fluid bolus). A subsequent increase in cardiac output indicates fluid responsiveness.